Back to search

Cornell University

TAKING ADVANTAGE OF NOVEL VULNERABILITIES FOR THE TREATMENT OF PANCREATIC CANCER

Abstract

dc:description.abstract

A vast majority of pancreatic ductal adenocarcinomas (PDACs) have mutations in KRAS. This type of cancer is also notoriously difficult to treat, often resulting in patient death. Thus, there is a clear need to better understand PDAC progression. Here, I have discovered that the cell survival protein Survivin is highly upregulated in KRAS-driven pancreatic cancer cells and blocking Survivin expression using YM155 causes cell death. Moreover, treating PDAC cells with small doses of YM155 and the heat shock protein 90 (HSP90) inhibitor, Geldanamycin, was found to strongly kill certain PDAC cells, suggesting that drug combinations that include Survivin inhibition may hold promise as treatments for PDAC. Moreover, a YM155-resistant PDAC cell line was generated, which could be a powerful tool to investigate the mechanisms of drug resistance. These findings highlight Survivin as an important player in PDAC, and provide new insights regarding potential treatments for this disease.

Degree

thesis:*
Name thesis:degree_name
M.S., Chemistry and Chemical Biology
Level thesis:degree_level
Master of Science
Discipline thesis:degree_discipline
Chemistry and Chemical Biology
Grantor
Cornell University
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Liu, Yinzhe
Chair dc:contributor.chair
  • Zax, David B.
Committee member dc:contributor.committeemember
  • Lancaster, Kyle M.

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
15160307
Dc Identifier Other
ProQuest Submission ID: 11279
ProQuest Publication ID: 28712714

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Liu, Yinzhe. TAKING ADVANTAGE OF NOVEL VULNERABILITIES FOR THE TREATMENT OF PANCREATIC CANCER. Master of Science thesis, Cornell University, 2021. https://hdl.handle.net/1813/110427